FindTrial
Sign In

Ferinject 50 mg/ml

DRUG2 trials

Sponsors

Assistance Publique Hopitaux De Paris, University Hospital Muenster

Conditions

AnemiaHigh Risk of Blood LossOrthopedic SurgeryWomen who delivered by caesarean and have a moderate postpartum iron deficiency anaemia defined by 8.0 g/dL ≤ postoperative Hb level ≤ 10.0 g/dL within 72h after delivery and a ferritinemia ≤ 100 ng/mL OR transferrin saturation ≤ 20% (Measured after postoperative Hb level measurement)

Phase 4

Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery
TerminatedNCT01345968
University Hospital MuensterAnemia, High Risk of Blood Loss, Orthopedic Surgery
Start: 2011-06-30End: 2013-02-28Updated: 2013-08-09
Treatment of anaemia after caesarean with intravenous versus oral iron and postpartum depression: a multicentric randomized open-labelled controlled trial (IRON-DEP)
RecruitingCTIS2023-503283-17-00
Assistance Publique Hopitaux De ParisWomen who delivered by caesarean and have a moderate postpartum iron deficiency anaemia defined by 8.0 g/dL ≤ postoperative Hb level ≤ 10.0 g/dL within 72h after delivery and a ferritinemia ≤ 100 ng/mL OR transferrin saturation ≤ 20% (Measured after postoperative Hb level measurement)
Start: 2025-10-22Target: 2860Updated: 2025-07-02